Let Us Help You Change the World

Life Science Angels, Inc. (LSA) is the premier angel investment group focused solely on healthcare investing, including medical devices, diagnostics, pharmaceuticals, biotechnology, and digital health

Top Angel Group in the United States / CB Insights

Who We Are

LSA is a group of accredited investors with significant experience in life science operations and investing. Members include prominent executives, physicians, scientists, attorneys, engineers, venture capitalists, and entrepreneurs. LSA members have been founders and senior level executives in companies throughout the healthcare space.

Identify Potential

Our members work tirelessly to identify and nurture top talent amongst life science entrepreneurs.

Foster Connections

Our members offer deep sector-specific experience and broad networks within all branches of life science.

Provide Funding

We lead equity investments to help early stage companies meet key objectives.

Support and Mentor

For those not yet ready for fundraising, we offer personalized feedback, advice and mentorship.

A Word From Our Portfolio Companies

  • We were able to tap into the LSA network to find additional clinical sites for our pivotal trial.

    Matthew Cooper
    Matthew CooperFounder & CEO, Carmenta Bioscience
  • At Life Science Angels, we found investors who believe in our products and share our passion for improving consumer healthcare.  In addition to leading our financing, LSA has brought Sandstone tremendous value by building relationships with other investors, making introductions to industry partners, and providing expert guidance to our founding team.  We're proud to be included among LSA's impressive investment portfolio.

    Greg Sommer
    Greg Sommer Co-Founder & CEO, Sandstone Diagnostics
  • LSA was the first angel group that invested in OncoHealth five years ago. The connection has also helped OncoHealth raise money from several angel groups. LSA has been most supportive of the company through good times and bad times, investing in every round of financing. Moreover, one can always tap into the diverse expertise, experiences, and connections of its members; several of them serve on the board of the company, providing strong and consistent support for management.

    Winnie Wan
    Winnie WanCEO and Co-Founder, OncoHealth

Our Portfolio Companies

LSA portfolio companies continue to improve the standard of care, which has translated into 10+ liquidity events including the acquisition of Nanostim by St. Jude Medical in 2013, the acquisition of CV Ingenuity by Covidien in 2013 and Zogenix’ IPO in 2010.

Get to Know Life Science Angels

Fuel Your Venture with LSA Support